Overview

Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Neuroblastoma is a malignant tumor that develops in infants and kids. Dysregulation of histone acetylation is associated with a series of malignant tumors. Neuroblastoma is caused by defective neural crest differentiation due to abnormal gene regulation.
Phase:
Phase 1
Details
Lead Sponsor:
Yizhuo Zhang
Treatments:
Etoposide